CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in IMRX — Immuneering Corp

CIK 884546 SAN FRANCISCO, CA

Position in IMRX

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$837,825

+$641,023 QoQ

Shares Held

167,901

+349.6% QoQ

Ownership

0.260%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#27

of 111 holders

Holding Since

Sep 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. IMRX ranks #236 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,041,282	$1,013,966,007
2	REGN	Regeneron Pharmaceuticals, Inc.	846,306	$527,705,642
3	RVMD	Revolution Medicines, Inc.	1,917,025	$359,020,441
4	MRNA	Moderna, Inc.	4,838,884	$338,867,045
5	ALNY	Alnylam Pharmaceuticals, Inc.	755,377	$227,391,137
6	INCY	Incyte Corp	1,692,439	$191,854,884
7	RPRX	Royalty Pharma plc	3,083,528	$172,893,414
8	CYTK	Cytokinetics Inc	1,565,781	$133,388,883

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$837,825	167,901	+349.6%	Shares	Sole	2026-08-14
2026-03-31	$196,802	37,344	+67.1%	Shares	Sole	2026-05-15
2025-12-31	$147,023	22,344	0.0%	Shares	Sole	2026-02-13
2025-09-30	$156,408	22,344	+86.2%	Shares	Sole	2025-11-10
2025-06-30	$40,440	12,000	0.0%	Shares	Sole	2025-08-12
2025-03-31	$18,240	12,000	-80.2%	Shares	Sole	2025-09-15
2024-03-31	$174,879	60,512	0.0%	Shares	Sole	2024-05-09
2023-12-31	$444,763	60,512	0.0%	Shares	Sole	2024-02-06
2023-09-30	$464,732	60,512	+9.9%	Shares	Sole	2023-11-08
2023-06-30	$558,105	55,040	+21.1%	Shares	Sole	2023-08-10
2022-03-31	$294,003	45,441	+112.4%	Shares	Sole	2022-05-13
2021-12-31	$345,989	21,397	+5.7%	Shares	Sole	2022-02-11
2021-09-30	$537,265	20,236	—	Shares	Sole	2021-11-16
No filing history on record for this holder in this stock.